SCHEMBL21101913

SCHEMBL21101913

CC(=O)Cc1cc(Cl)cc(C(C)(C)F)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.34
PLA2G1B P04054 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
GAA P10253 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ATG4B Q9Y4P1 1/20 0.34
ANO1 Q5XXA6 2/20 0.33
SLC13A3 Q8WWT9 1/20 0.32
GRN P28799 1/20 0.32
SORT1 Q99523 1/20 0.32
ALDH1A1 P00352 1/20 0.32
FAAH O00519 1/20 0.32
DDR1 Q08345 3/20 0.32
TACR1 P25103 2/20 0.31
LMNA P02545 1/20 0.31
P2RX1 P51575 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21101918 0.88 TACR1 (0.37) CYP1A2CYP3A4CYP2D6CYP2C19TACR1
SCHEMBL21101912 0.83 TACR1 (0.35) CYP1A2CYP2D6CYP2C19TACR1
SCHEMBL48901 0.80 IDO1 (0.43) CYP3A4GAAANO1GRNSORT1
SCHEMBL21101909 0.75 CYP1A2 (0.50) MEN1CYP1A2CYP2C19KMT2AALDH1A1
SCHEMBL6492340 0.74 IDO1 (0.48) CYP1A2CYP2D6CYP2C19TACR1
SCHEMBL21101779 0.74 FFAR4 (0.46) DDR1RAPGEF3CNR1
SCHEMBL21101910 0.73 POLB (0.46) CYP2C19LMNA
SCHEMBL22775743 0.72 SLC13A3 (0.42) MEN1PLA2G1BCYP1A2CYP3A4GAA
SCHEMBL10153376 0.72 RXRA (0.54) MEN1PLA2G1BCYP1A2CYP3A4GAA
SCHEMBL4286759 0.72 RXRA (0.49) MEN1CYP1A2CYP2C19KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111225-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS AVALIV THERAPEUTICS (US) 2019-06-13 WO disclosed